Epigenetics in endometrial carcinogenesis – part 1: DNA methylation

References

• Bokhman JV . Two pathogenetic types of endometrial carcinoma . Gynecol. Oncol.15 ( 1 ), 10 – 17 ( 1983 ).
   PubMed Web of Science ®Google Scholar
• Matias-Guiu X , PratJ . Molecular pathology of endometrial carcinoma . Histopathology62 ( 1 ), 111 – 123 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• O’hara AJ , BellDW . The genomics and genetics of endometrial cancer . Adv. Genomics Genet.2012 ( 2 ), 33 – 47 ( 2012 ).
   PubMedGoogle Scholar
• Morice P , LearyA , CreutzbergC , Abu-RustumN , DaraiE . Endometrial cancer . Lancet387 ( 10023 ), 1094 – 108 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mulac-Jericevic B , MullinaxRA , DemayoFJ , LydonJP , ConneelyOM . Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform . Science289 ( 5485 ), 1751 – 1754 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Miyamoto T , WatanabeJ , HataHet al. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma . J. Steroid. Biochem. Mol. Biol.92 ( 3 ), 111 – 118 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Jongen V , BrietJ , De JongRet al. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer . Gynecol. Oncol.112 ( 3 ), 537 – 542 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zannoni GF , MonterossiG , De StefanoIet al. The expression ratios of estrogen receptor alpha (ERalpha) to estrogen receptor beta1 (ERbeta1) and ERalpha to ERbeta2 identify poor clinical outcome in endometrioid endometrial cancer . Hum. Pathol.44 ( 6 ), 1047 – 1054 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Decruze SB , GreenJA . Hormone therapy in advanced and recurrent endometrial cancer: a systematic review . Int. J. Gynecol. Cancer17 ( 5 ), 964 – 978 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Leenen CH , Van LierMG , Van DoornHCet al. Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer </=70 years . Gynecol. Oncol.125 ( 2 ), 414 – 420 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mahdi H , MesterJL , NizialekEA , NgeowJ , MichenerC , EngC . Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study . Cancer121 ( 5 ), 688 – 696 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Haraldsdottir S , HampelH , TomsicJet al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations . Gastroenterology147 ( 6 ), 1308 – 1316 , e1301 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kawaguchi M , BannoK , YanokuraMet al. Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer . Int. J. Oncol.35 ( 5 ), 977 – 982 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zhou XP , KuismanenS , Nystrom-LahtiM , PeltomakiP , EngC . Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared with sporadic microsatellite unstable tumors . Hum. Mol. Genet.11 ( 4 ), 445 – 450 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Moreno-Bueno G , HardissonD , SanchezCet al. Abnormalities of the APC/beta-catenin pathway in endometrial cancer . Oncogene21 ( 52 ), 7981 – 7990 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Hoang LN , McconechyMK , MengBet al. Targeted mutation analysis of endometrial clear cell carcinoma . Histopathology66 ( 5 ), 664 – 674 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bae HS , KimH , Young KwonS , KimKR , SongJY , KimI . Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?Int. J. Gynecol. Pathol.34 ( 1 ), 74 – 84 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N , KandothC , SchultzNet al. Integrated genomic characterization of endometrial carcinoma . Nature497 ( 7447 ), 67 – 73 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sandoval J , EstellerM . Cancer epigenomics: beyond genomics . Curr. Opin. Genet. Dev.22 ( 1 ), 50 – 55 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Schultz MD , HeY , WhitakerJWet al. Human body epigenome maps reveal noncanonical DNA methylation variation . Nature523 ( 7559 ), 212 – 216 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond . Nat. Rev. Genet.13 ( 7 ), 484 – 492 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kulis M , QueirosAC , BeekmanR , Martin-SuberoJI . Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer . Biochim. Biophys. Acta1829 ( 11 ), 1161 – 1174 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• García-Giménez JL . Epigenetic Biomarkers and Diagnostics.Academic Press ( 2016 ).
   Google Scholar
• Jeong M , GoodellMA . New answers to old questions from genome-wide maps of DNA methylation in hematopoietic cells . Exp. Hematol.42 ( 8 ), 609 – 617 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bell RE , GolanT , MalcovHet al. Enhancer methylation dynamics contribute to cancer plasticity and patient mortality . Genome Res.26 ( 5 ), 601 – 611 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Du J , JohnsonLM , JacobsenSE , PatelDJ . DNA methylation pathways and their crosstalk with histone methylation . Nat. Rev. Mol. Cell Biol.16 ( 9 ), 519 – 532 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hamidi T , SinghAK , ChenT . Genetic alterations of DNA methylation machinery in human diseases . Epigenomics7 ( 2 ), 247 – 265 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Schubeler D . Function and information content of DNA methylation . Nature517 ( 7534 ), 321 – 326 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Baylin SB . Epigenetics and cancer . In : The Molecular Basis of Cancer.MendelsohnJ , HowleyPM , IsraelMA , GrayJW , ThompsonCB ( Eds ). Elsevier Health Sciences , PA, USA , 67 – 78 ( 2014 ).
   Google Scholar
• Ghabreau L , RouxJP , NiveleauAet al. Correlation between the DNA global methylation status and progesterone receptor expression in normal endometrium, endometrioid adenocarcinoma and precursors . Virchows Archiv.445 ( 2 ), 129 – 134 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Houshdaran S , ZelenkoZ , IrwinJC , GiudiceLC . Human endometrial DNA methylome is cycle-dependent and is associated with gene expression regulation . Mol. Endocrinol.28 ( 7 ), 1118 – 1135 ( 2014 ).
   PubMedGoogle Scholar
• Vincent ZL , FarquharCM , MitchellMD , PonnampalamAP . Expression and regulation of DNA methyltransferases in human endometrium . Fertil. Steril.95 ( 4 ), 1522 – 1525e1521 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Van Kaam KJ , DelvouxB , RomanoA , D’hoogheT , DunselmanGA , GroothuisPG . Deoxyribonucleic acid methyltransferases and methyl-CpG-binding domain proteins in human endometrium and endometriosis . Fertil. Steril.95 ( 4 ), 1421 – 1427 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yamagata Y , AsadaH , TamuraIet al. DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen . Hum. Reprod.24 ( 5 ), 1126 – 1132 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Issa JP . CpG island methylator phenotype in cancer . Nat. Rev. Cancer4 ( 12 ), 988 – 993 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Kanaya T , KyoS , MaidaYet al. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers . Oncogene22 ( 15 ), 2352 – 2360 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Van Vlodrop IJ , NiessenHE , DerksSet al. Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clin. Cancer Res. 17 ( 13 ), 4225 – 4231 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Frigola J , SongJ , StirzakerC , HinshelwoodRA , PeinadoMA , ClarkSJ . Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band . Nat. Genet.38 ( 5 ), 540 – 549 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Olkhov-Mitsel E , BapatB . Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers . Cancer Med.1 ( 2 ), 237 – 260 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Sun Z , CunninghamJ , SlagerS , KocherJP . Base resolution methylome profiling: considerations in platform selection, data preprocessing and analysis . Epigenomics7 ( 5 ), 813 – 828 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chatterjee A , RodgerEJ , MorisonIM , EcclesMR , StockwellPA . Tools and strategies for analysis of genome-wide and gene-specific DNA methylation patterns . Methods Mol. Biol.1537 , 249 – 277 ( 2017 ).
   PubMedGoogle Scholar
• Tost J . Current and emerging technologies for the analysis of the genome-wide and locus-specific DNA methylation patterns . Adv. Exp. Med. Biol.945 , 343 – 430 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Postawski K , Galecka-JosseM , BaranowskiW . Is global DNA methylation in sporadic uterine adenocarcinomas in women a result of histological and clinical tumor advancement?Ginekol. Pol.80 ( 11 ), 824 – 827 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zhang B , XingX , LiJet al. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers . BMC Genomics15 , 868 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hori M , IwasakiM , ShimazakiJ , InagawaS , ItabashiM . Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases . Gynecol. Oncol.76 ( 1 ), 89 – 96 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Navari JR , RolandPY , KehPet al. Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5’ end of the ER gene . Clin. Cancer Res.6 ( 10 ), 4026 – 4032 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Sasaki M , KotcherguinaL , DhariaA , FujimotoS , DahiyaR . Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer . Cancer Res.61 ( 8 ), 3262 – 3266 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Shiozawa T , ItohK , HoriuchiA , KonishiI , FujiiS , NikaidoT . Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma . Anticancer Res.22 ( 1A ), 139 – 143 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Maeda K , TsudaH , HashiguchiYet al. Relationship between p53 pathway and estrogen receptor status in endometrioid-type endometrial cancer . Hum. Pathol.33 ( 4 ), 386 – 391 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Sasaki M , DhariaA , OhBR , TanakaY , FujimotoS , DahiyaR . Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer . Cancer Res.61 ( 1 ), 97 – 102 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Xiong Y , DowdySC , Gonzalez BosquetJet al. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines . Gynecol. Oncol.99 ( 1 ), 135 – 141 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Yang S , JiaY , LiuXet al. Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer . Oncotarget5 ( 20 ), 9783 – 9797 ( 2014 ).
   PubMedGoogle Scholar
• Bartosch C , Monteiro-ReisS , VieiraRet al. Endometrial endometrioid carcinoma metastases show decreased ER-alpha and PR-A expression compared to matched primary tumors . PLoS ONE10 ( 8 ), e0134969 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang QY , YiDQ , ZhouL , ZhangDH , ZhouTM . Status and significance of CpG island methylator phenotype in endometrial cancer . Gynecol. Obstet. Invest.72 ( 3 ), 183 – 191 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Smid-Koopman E , BlokLJ , KuhneLCet al. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines . J. Soc. Gynecol. Investig.10 ( 1 ), 49 – 57 ( 2003 ).
   PubMedGoogle Scholar
• Dai D , WolfDM , LitmanES , WhiteMJ , LeslieKK . Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors . Cancer Res.62 ( 3 ), 881 – 886 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Sakaguchi H , FujimotoJ , HongBL , NakagawaY , TamayaT . Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers . Gynecol. Oncol.93 ( 2 ), 394 – 399 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Kumar NS , RicherJ , OwenG , LitmanE , HorwitzKB , LeslieKK . Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action . Cancer Res.58 ( 9 ), 1860 – 1865 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Wen DX , XuYF , MaisDE , GoldmanME , McdonnellDP . The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells . Mol. Cell Biol.14 ( 12 ), 8356 – 8364 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Ren Y , LiuX , MaD , FengY , ZhongN . Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cells . Cancer Genet. Cytogenet.175 ( 2 ), 107 – 116 ( 2007 ).
   PubMedGoogle Scholar
• Tamm-Rosenstein K , SimmJ , SuhorutshenkoM , SalumetsA , MetsisM . Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing . PLoS ONE8 ( 7 ), e68907 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Tao MH , FreudenheimJL . DNA methylation in endometrial cancer . Epigenetics5 ( 6 ), 491 – 498 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ChenH . Genistein, an epigenome modifier during cancer prevention . Epigenetics6 ( 7 ), 888 – 891 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wong RL , WalkerCL . Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome . Clin. Cancer Res.19 ( 14 ), 3732 – 3737 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Crujeiras AB , CasanuevaFF . Obesity and the reproductive system disorders: epigenetics as a potential bridge . Hum. Reprod. Update21 ( 2 ), 249 – 261 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Dick KJ , NelsonCP , TsaprouniLet al. DNA methylation and body-mass index: a genome-wide analysis . Lancet383 ( 9933 ), 1990 – 1998 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Xu X , SuS , BarnesVAet al. A genome-wide methylation study on obesity: differential variability and differential methylation . Epigenetics8 ( 5 ), 522 – 533 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Milagro FI , Gomez-AbellanP , CampionJ , MartinezJA , OrdovasJM , GarauletM . CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake . Chronobiol. Int.29 ( 9 ), 1180 – 1194 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Skinner MK , Guerrero-BosagnaC . Role of CpG deserts in the epigenetic transgenerational inheritance of differential DNA methylation regions . BMC Genomics15 , 692 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mentch SJ , LocasaleJW . One-carbon metabolism and epigenetics: understanding the specificity . Ann. NY Acad. Sci.1363 , 91 – 98 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kim YI , PogribnyIP , BasnakianAGet al. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene . Am. J. Clin. Nutr.65 ( 1 ), 46 – 52 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Pogribny IP , JamesSJ . De novo methylation of the p16 INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats . Cancer Lett.187 ( 1–2 ), 69 – 75 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Uccella S , MarianiA , WangAHet al. Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: a prospective cohort study . Ann. Oncol.22 ( 9 ), 2129 – 2136 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Harris HR , CramerDW , VitonisAF , DepariM , TerryKL . Folate, vitamin B(6), vitamin B(12), methionine and alcohol intake in relation to ovarian cancer risk . Int. J. Cancer131 ( 4 ), E518 – E529 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hanley MP , RosenbergDW . One-carbon metabolism and colorectal cancer: potential mechanisms of chemoprevention . Curr. Pharmacol. Rep.1 ( 3 ), 197 – 205 ( 2015 ).
   PubMedGoogle Scholar
• Mccullough LE , ChenJ , WhiteAJet al. Gene-specific promoter methylation status in hormone-receptor-positive breast cancer associates with postmenopausal body size and recreational physical activity . Int. J. Cancer Clin. Res.2 ( 1 ), pii: 013 ( 2015 ).
   Google Scholar
• Coyle YM , XieXJ , LewisCM , BuD , MilchgrubS , EuhusDM . Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in nonmalignant breast tissue . Cancer Epidemiol. Biomark. Prev.16 ( 2 ), 192 – 196 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Herman JG , UmarA , PolyakKet al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma . Proc. Natl Acad. Sci. USA95 ( 12 ), 6870 – 6875 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Cui M , WenZ , ChenJ , YangZ , ZhangH . 5-Aza-2’-deoxycytidine is a potent inhibitor of DNA methyltransferase 3B and induces apoptosis in human endometrial cancer cell lines with the up-regulation of hMLH1 . Med. Oncol.27 ( 2 ), 278 – 285 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bischoff J , IgnatovA , SemczukAet al. hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases . Clin. Exp. Metastasis29 ( 8 ), 889 – 900 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Whitcomb BP , MutchDG , HerzogTJ , RaderJS , GibbRK , GoodfellowPJ . Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma . Clin. Cancer Res.9 ( 6 ), 2277 – 2287 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Simpkins SB , BockerT , SwisherEMet al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers . Hum. Mol. Genet.8 ( 4 ), 661 – 666 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Salvesen HB , MacdonaldN , RyanAet al. Methylation of hMLH1 in a population-based series of endometrial carcinomas . Clin. Cancer Res.6 ( 9 ), 3607 – 3613 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Esteller M , CatasusL , Matias-GuiuXet al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis . Am. J. Pathol.155 ( 5 ), 1767 – 1772 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Pai RK , PlesecTP , Abdul-KarimFWet al. Abrupt loss of MLH1 and PMS2 expression in endometrial carcinoma: molecular and morphologic analysis of 6 cases . Am. J. Surg. Pathol.39 ( 7 ), 993 – 999 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Horowitz N , PintoK , MutchDGet al. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia . Gynecol. Oncol.86 ( 1 ), 62 – 68 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Guida M , SanguedolceF , BufoPet al. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions . Eur. J. Gynaecol. Oncol.30 ( 3 ), 267 – 270 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Pijnenborg JM , Dam-De VeenGC , De HaanJ , Van EngelandM , GroothuisPG . Defective mismatch repair and the development of recurrent endometrial carcinoma . Gynecol. Oncol.94 ( 2 ), 550 – 559 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Esteller M , LevineR , BaylinSB , EllensonLH , HermanJG . MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas . Oncogene17 ( 18 ), 2413 – 2417 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Kondo E , FurukawaT , YoshinagaKet al. Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability . Int. J. Oncol.17 ( 3 ), 535 – 541 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Zighelboim I , GoodfellowPJ , GaoFet al. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type . J. Clin. Oncol.25 ( 15 ), 2042 – 2048 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Yang HJ , LiuVW , WangY , TsangPC , NganHY . Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data . BMC Cancer6 , 212 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Banno K , YanokuraM , SusumuNet al. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer . Oncol. Rep.16 ( 6 ), 1189 – 1196 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Suehiro Y , OkadaT , OkadaTet al. Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation . Clin. Cancer Res.14 ( 11 ), 3354 – 3361 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Seeber LM , ZweemerRP , MarchionniLet al. Methylation profiles of endometrioid and serous endometrial cancers . Endocr. Relat. Cancer17 ( 3 ), 663 – 673 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Macdonald ND , SalvesenHB , RyanAet al. Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series . Int. J. Gynecol. Cancer14 ( 5 ), 957 – 965 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Furlan D , CarnevaliI , MarcominiBet al. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas . Clin. Cancer Res.12 ( 11 Pt 1 ), 3329 – 3336 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Nagy E , GajjarKB , PatelIIet al. MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases . Br. J. Cancer110 ( 12 ), 2874 – 2880 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Rimel BJ , HuettnerP , PowellMA , MutchDG , GoodfellowPJ . Absence of MGMT promoter methylation in endometrial cancer . Gynecol. Oncol.112 ( 1 ), 224 – 228 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Esteller M , HamiltonSR , BurgerPC , BaylinSB , HermanJG . Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia . Cancer Res.59 ( 4 ), 793 – 797 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Jacinto FV , EstellerM . Mutator pathways unleashed by epigenetic silencing in human cancer . Mutagenesis22 ( 4 ), 247 – 253 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lee KE . Immunohistochemical assessment of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and its relationship with p53 expression in endometrial cancers . J. Cancer Prev.18 ( 4 ), 351 – 354 ( 2013 ).
   PubMedGoogle Scholar
• Chen Z , CheQ , JiangFZet al. Piwil1 causes epigenetic alteration of PTEN gene via upregulation of DNA methyltransferase in type I endometrial cancer . Biochem. Biophys. Res. Commun.463 ( 4 ), 876 – 880 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Salvesen HB , MacdonaldN , RyanAet al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma . Int. J. Cancer91 ( 1 ), 22 – 26 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Velasco A , BussagliaE , PallaresJet al. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations . Hum. Pathol.37 ( 11 ), 1465 – 1472 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Salvesen HB , StefanssonI , KretzschmarEIet al. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression . Int. J. Oncol.25 ( 6 ), 1615 – 1623 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Zysman MA , ChapmanWB , BapatB . Considerations when analyzing the methylation status of PTEN tumor suppressor gene . Am. J. Pathol.160 ( 3 ), 795 – 800 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Liao X , SiuMK , ChanKYet al. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis . Int. J. Cancer123 ( 2 ), 296 – 302 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Pallares J , VelascoA , EritjaNet al. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma . Mod. Pathol.21 ( 6 ), 691 – 699 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kang S , SeoSS , ChangHJ , YooCW , ParkSY , DongSM . Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma . Int. J. Gynecol. Cancer18 ( 6 ), 1339 – 1343 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Jo H , KimJW , KangGHet al. Association of promoter hypermethylation of the RASSF1A gene with prognostic parameters in endometrial cancer . Oncol. Res.16 ( 4 ), 205 – 209 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kang S , LeeJM , JeonESet al. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma . Int. J. Cancer119 ( 6 ), 1316 – 1321 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kang S , KimJW , KangGHet al. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma . Int. J. Cancer118 ( 9 ), 2168 – 2171 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Pijnenborg JM , Dam-De VeenGC , KistersNet al. RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer . Ann. Oncol.18 ( 3 ), 491 – 497 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Fiolka R , ZuborP , JanusicovaVet al. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer . Oncol. Rep.30 ( 6 ), 2878 – 2886 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Arafa M , KridelkaF , MathiasVet al. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma . Histopathology53 ( 5 ), 525 – 532 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Nieminen TT , GyllingA , Abdel-RahmanWMet al. Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia . Clin. Cancer Res.15 ( 18 ), 5772 – 5783 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Joensuu EI , Abdel-RahmanWM , OllikainenM , RuosaariS , KnuutilaS , PeltomakiP . Epigenetic signatures of familial cancer are characteristic of tumor type and family category . Cancer Res.68 ( 12 ), 4597 – 4605 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Visnovsky J , FiolkaR , KudelaEet al. Hypermethylation of selected genes in endometrial carcinogenesis . Neuro Endocrinol. Lett.34 ( 7 ), 675 – 680 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Velasco A , PallaresJ , SantacanaMet al. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma . Hum. Pathol.42 ( 2 ), 185 – 193 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Dewdney SB , RimelBJ , ThakerPHet al. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers . Clin. Cancer Res.17 ( 8 ), 2120 – 2129 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ignatov A , BischoffJ , IgnatovTet al. APC promoter hypermethylation is an early event in endometrial tumorigenesis . Cancer Sci.101 ( 2 ), 321 – 327 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pijnenborg JM , KistersN , Van EngelandMet al. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma . Int. J. Gynecol. Cancer14 ( 5 ), 947 – 956 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Zysman M , SakaA , MillarA , KnightJ , ChapmanW , BapatB . Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype . Cancer Res.62 ( 13 ), 3663 – 3666 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Nishimura M , SaitoT , YamasakiH , KudoR . Suppression of gap junctional intercellular communication via 5’ CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells . Carcinogenesis24 ( 10 ), 1615 – 1623 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Saito T , NishimuraM , YamasakiH , KudoR . Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma . Cancer97 ( 4 ), 1002 – 1009 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Yi TZ , GuoJ , ZhouLet al. Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinoma . Cancer Invest.29 ( 1 ), 86 – 92 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yi TZ , LiJ , HanXet al. DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo . Chemotherapy58 ( 1 ), 19 – 29 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Park JH , LeeBI , SongES , WhangSO , LeeWY , ChoSJ . Hypermethylation of E-cadherin in endometrial carcinoma . J. Gynecol. Oncol.19 ( 4 ), 241 – 245 ( 2008 ).
   PubMedGoogle Scholar
• Moreno-Bueno G , HardissonD , SarrioDet al. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia . J. Pathol.199 ( 4 ), 471 – 478 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Risinger JI , MaxwellGL , ChandramouliGVet al. Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling . Cancer Res.65 ( 12 ), 5031 – 5037 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Di Domenico M , SantoroA , RicciardiCet al. Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization . Cancer Biol. Ther.12 ( 5 ), 447 – 457 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhao Y , YangY , TrovikJet al. A novel Wnt regulatory axis in endometrioid endometrial cancer . Cancer Res.74 ( 18 ), 5103 – 5117 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sheng Y , WangH , LiuDet al. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma . Gynecol. Oncol.140 ( 1 ), 145 – 151 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Dvorakova E , ChmelarovaM , LacoJ , PalickaV , SpacekJ . Methylation analysis of tumor suppressor genes in endometrioid carcinoma of endometrium using MS-MLPA . Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.157 ( 4 ), 298 – 303 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Salvesen HB , DasS , AkslenLA . Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis . Clin. Cancer Res.6 ( 1 ), 153 – 159 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Salvesen HB , KumarR , StefanssonIet al. Low frequency of BRAF and CDKN2A mutations in endometrial cancer . Int. J. Cancer115 ( 6 ), 930 – 934 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Yanokura M , BannoK , SusumuNet al. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients . Anticancer Res.26 ( 2A ), 851 – 856 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Nakashima R , FujitaM , EnomotoTet al. Alteration of p16 and p15 genes in human uterine tumours . Br. J. Cancer80 ( 3–4 ), 458 – 467 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Semczuk A , BoltzeC , MarzecB , SzczygielskaA , RoessnerA , Schneider-StockR . p16 INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas . J. Cancer Res. Clin. Oncol.129 ( 10 ), 589 – 596 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Tsuda H , YamamotoK , InoueT , UchiyamaI , UmesakiN . The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma . Br. J. Cancer82 ( 3 ), 675 – 682 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Ignatov A , BischoffJ , SchwarzenauCet al. P16 alterations increase the metastatic potential of endometrial carcinoma . Gynecol. Oncol.111 ( 2 ), 365 – 371 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wong YF , ChungTK , CheungTHet al. Methylation of p16 INK4A in primary gynecologic malignancy . Cancer Lett.136 ( 2 ), 231 – 235 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Hu ZY , TangLD , ZhouQ , XiaoL , CaoY . Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma . Tumour Biol.36 ( 3 ), 1487 – 1491 ( 2015 ).
   PubMedGoogle Scholar
• Hoivik EA , KusonmanoK , HalleMKet al. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene . Oncotarget5 ( 4 ), 1052 – 1061 ( 2014 ).
   PubMedGoogle Scholar
• Wu H , ChenY , LiangJet al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis . Nature438 ( 7070 ), 981 – 987 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Monte NM , WebsterKA , NeubergD , DresslerGR , MutterGL . Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer . Cancer Res.70 ( 15 ), 6225 – 6232 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Allison KH , UpsonK , ReedSDet al. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia . Int. J. Gynecol. Pathol.31 ( 2 ), 151 – 159 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Toyota M , AhujaN , Ohe-ToyotaM , HermanJG , BaylinSB , IssaJP . CpG island methylator phenotype in colorectal cancer . Proc. Natl Acad. Sci. USA96 ( 15 ), 8681 – 8686 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Zighelboim I , GoodfellowPJ , SchmidtAPet al. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers . Clin. Cancer Res.13 ( 10 ), 2882 – 2889 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Hsu YT , GuF , HuangYWet al. Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancer . Clin. Cancer Res.19 ( 22 ), 6272 – 6285 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Risinger JI , MaxwellGL , BerchuckA , BarrettJC . Promoter hypermethylation as an epigenetic component in type I and type II endometrial cancers . Ann. NY Acad. Sci.983 , 208 – 212 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Ikeda S , ImuraJ , SuzukiK . Protein expression, mRNA expression and gene amplification of DNA methyltransferase 1 in endometrial tumor tissues . Mol. Clin. Oncol.1 ( 3 ), 423 – 429 ( 2013 ).
   PubMedGoogle Scholar
• Joensuu EI , NieminenTT , LotsariJE , PavicicW , Abdel-RahmanWM , PeltomakiP . Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer . Genes, Chromosomes Cancer54 ( 12 ), 776 – 787 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Xiong Y , DowdySC , XueAet al. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers . Gynecol. Oncol.96 ( 3 ), 601 – 609 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Xu S , RenJ , ChenHBet al. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells . Curr. Pharm. Design.20 ( 11 ), 1881 – 1887 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Xiong Y , DowdySC , EberhardtNL , PodratzKC , JiangSW . hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications . Gynecol. Oncol.103 ( 1 ), 321 – 328 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Chu Y , WangY , ZhangGet al. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers . Cell. Mol. Life Sci.71 ( 17 ), 3393 – 3408 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Fiegl H , GattringerC , WidschwendterAet al. Methylated DNA collected by tampons-a new tool to detect endometrial cancer . Cancer Epidemiol. Biomark. Prev.13 ( 5 ), 882 – 888 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Bakkum-Gamez JN , WentzensenN , MaurerMJet al. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons . Gynecol. Oncol.137 ( 1 ), 14 – 22 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Huang RL , SuPH , LiaoYPet al. Integrated epigenomics analysis reveals a DNA methylation panel for endometrial cancer detection using cervical scrapings . Clin. Cancer Res.23 ( 1 ), 263 – 272 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Wentzensen N , Bakkum-GamezJN , KillianJKet al. Discovery and validation of methylation markers for endometrial cancer . Int. J. Cancer135 ( 8 ), 1860 – 1868 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Farkas SA , SorbeBG , NilssonTK . Epigenetic changes as prognostic predictors in endometrial carcinomas . Epigenetics12 ( 1 ), 19 – 26 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Wang X , YangY , XuCet al. CHFR suppression by hypermethylation sensitizes endometrial cancer cells to paclitaxel . Int. J. Gynecol. Cancer21 ( 6 ), 996 – 1003 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yanokura M , BannoK , KawaguchiMet al. Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer . Oncol. Rep.17 ( 1 ), 41 – 48 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Janzen DM , RosalesMA , PaikDYet al. Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy . Cancer Res.73 ( 15 ), 4697 – 4710 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Duenas-Gonzalez A , Medina-FrancoJL , Chavez-BlancoA , Dominguez-GomezG , Fernandez-De GortariE . Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers . Expert Opin. Pharmacother.17 ( 3 ), 323 – 338 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Sasaki M , OhBR , DhariaA , FujimotoS , DahiyaR . Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer . Mol. Carcinog.29 ( 2 ), 59 – 66 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Huang YW , LuoJ , WengYIet al. Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas . Gynecol. Oncol.117 ( 2 ), 239 – 247 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sasaki M , KaneuchiM , SakuragiN , DahiyaR . Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer . Cancer Res.63 ( 12 ), 3101 – 3106 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Shih MC , YehKT , TangKP , ChenJC , ChangJG . Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR . Mol. Carcinog.45 ( 10 ), 732 – 740 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Yang T , QiuH , BaoWet al. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma . PLoS ONE8 ( 6 ), e67458 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Buchynska LG , IurchenkoNP , VerkoNP , NekrasovKA , KashubaVI . FOXP3 gene promoter methylation in endometrial cancer cells . Exp. Oncol.37 ( 4 ), 246 – 249 ( 2015 ).
   PubMedGoogle Scholar
• Chmelarova M , KosS , DvorakovaEet al. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium . Clin. Chem. Lab. Med.52 ( 8 ), 1229 – 1234 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kang HS , BabaT , MandaiMet al. GPR54 is a target for suppression of metastasis in endometrial cancer . Mol. Cancer Ther.10 ( 4 ), 580 – 590 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chan QK , KhooUS , ChanKYet al. Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma . J. Mol. Diagn.7 ( 1 ), 8 – 16 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Yoshida H , BroaddusR , ChengW , XieS , NaoraH . Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial-mesenchymal transition . Cancer Res.66 ( 2 ), 889 – 897 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Yamaguchi S , AsanomaK , TakaoT , KatoK , WakeN . Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor . Int. J. Cancer124 ( 11 ), 2577 – 2588 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Fambrini M , BussaniC , SorbiF , PieralliA , CioniR . Methylation of the HOXA10 homeobox gene promoter is associated with endometrial cancer: a pilot study . J. Obstetr. Gynaecol.33 ( 5 ), 519 – 520 ( 2013 ).
   Web of Science ®Google Scholar
• Chen YC , TsaoCM , KuoCCet al. Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis . Taiwan J. Obstet. Gynecol.54 ( 5 ), 572 – 579 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Schirmer U , FieglH , PfeiferMet al. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens . BMC Cancer13 , 156 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Tse KY , LiuVW , ChanDWet al. Epigenetic alteration of the metallothionein 1E gene in human endometrial carcinomas . Tumour Biol.30 ( 2 ), 93 – 99 ( 2009 ).
   PubMedGoogle Scholar
• Moreno-Bueno G , Fernandez-MarcosPJ , ColladoMet al. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer . Cancer Res.67 ( 5 ), 1927 – 1934 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Dowdy SC , GostoutBS , ShridharVet al. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines . Gynecol. Oncol.99 ( 1 ), 126 – 134 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Yeh KT , YangMY , LiuTCet al. Abnormal expression of period 1 (PER1) in endometrial carcinoma . J. Pathol.206 ( 1 ), 111 – 120 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Mhawech-Fauceglia P , SmiragliaDJ , BsharaWet al. Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma . Cancer Epidemiol. Biomark. Prev.17 ( 3 ), 571 – 577 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Li R , SaitoT , TanakaRet al. Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium . Cancer Lett.219 ( 1 ), 33 – 40 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Kim TY , LeeHJ , HwangKSet al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma . Lab. Invest.84 ( 4 ), 479 – 484 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Yoshizaki T , EnomotoT , FujitaMet al. Frequent inactivation of RUNX3 in endometrial carcinoma . Gynecol. Oncol.110 ( 3 ), 439 – 444 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Chen H , ZhangC , ShengYet al. Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma . Am. J. Cancer Res.5 ( 1 ), 180 – 190 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Wong OG , HuoZ , SiuMKet al. Hypermethylation of SOX2 promoter in endometrial carcinogenesis . Obstet. Gynecol. Int.2010 , pii: 682504 ( 2010 ).
   Google Scholar
• Dong R , PuH , WangY , YuJ , LianK , MaoC . TESTIN was commonly hypermethylated and involved in the epithelial-mesenchymal transition of endometrial cancer . Acta Pathologica Microbiologica, Et Immunologica Scandinavica123 ( 5 ), 394 – 400 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Catasus L , PonsC , MunozJ , EspinosaI , PratJ . Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas . Histopathology62 ( 4 ), 632 – 641 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Mhawech P , BenzA , CeratoCet al. Downregulation of 14–3–3 sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation . Mod. Pathol.18 ( 3 ), 340 – 348 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Suzuki F , NagaseS , SuzukiKet al. Decreased expression of 14–3–3 sigma is predictive of poor prognosis for patients with human uterine papillary serous carcinoma . Tohoku J. Exp. Med.231 ( 3 ), 193 – 199 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sanchez-Vega F , GoteaV , PetrykowskaHMet al. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines . Epigenetics8 ( 12 ), 1355 – 1372 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bi FF , LiD , YangQ . Hypomethylation of ETS transcription factor binding sites and upregulation of PARP1 expression in endometrial cancer . BioMed. Res. Int.2013 , 946268 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Xie R , LooseDS , ShipleyGL , XieS , BassettRLJr. , BroaddusRR . Hypomethylation-induced expression of S100A4 in endometrial carcinoma . Mod. Pathol.20 ( 10 ), 1045 – 1054 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Nakayama H , SanoT , MotegiA , OyamaT , NakajimaT . Increasing 14–3–3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma . Pathol. Int.55 ( 11 ), 707 – 715 ( 2005 ).
   PubMed Web of Science ®Google Scholar